Industry: Medical Devices & Consumables
Published Date: 2025-09-10
Pages: 99 Pages
Report ld: 4843157
Request Sample
Customized Report
Thromboelastography Analyzer Market Size(US$)

CAGR 2025-2031
9.1%
Market Size,2031
USD 766
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Thromboelastography Analyzer market size was US$ 420 million in 2024 and is forecast to a readjusted size of US$ 766 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Thromboelastography Analyzer market competitiveness, regional economic performance, and supply chain configurations.
Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
In recent years, the annual growth rate of the thromboelastography analyzers market has remained at a high level, showing the strong growth momentum of the market. This growth is mainly due to the advancement of medical technology, the increase in clinical demand and the intensification of market competition.
The key players of Thromboelastography Analyzer include Haemonetics, WerfenLife, Framar Hemologix srl, Sienco, etc. The top two players of Thromboelastography Analyzer account for approximately 53% of the total market. North America is the largest market of Thromboelastography Analyzer accounting for about 37%, followed by Europe and Asia Pacific.
Thromboelastography analyzers are widely used in multiple medical fields, including operating rooms, emergency rooms, intensive care units (ICUs), anesthesia departments, cardiology departments, etc. In these fields, thromboelastographs play an important role, helping doctors to monitor the coagulation status of patients in real time, assess surgical risks, guide clinical treatment and medication, etc.
Technological progress is one of the key factors driving market development. The technology of thromboelastography analyzer is constantly updated, including the improvement of automation, the enhancement of detection accuracy and the improvement of operation convenience. In addition, with the development of medical informatization, the digitization and networking of thromboelastography analyzers are also future development trends.
In general, the thromboelastography analyzers market has broad prospects. With the continuous advancement of technology and the growth of market demand, it is expected to continue to maintain a steady growth trend in the next few years. Investors are also paying more and more attention to this field, and the market potential is huge.
The global Thromboelastography Analyzer market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Thromboelastography Analyzer market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Four and Six Channels in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Maternal and Child Health Service in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Thromboelastography Analyzer value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Thromboelastography Analyzer Product Scope
1.2 Thromboelastography Analyzer by Type
1.2.1 Global Thromboelastography Analyzer Sales by Type (2020 & 2024 & 2031)
1.2.2 Single and Double Channels
1.2.3 Four and Six Channels
1.2.4 Others
1.3 Thromboelastography Analyzer by Application
1.3.1 Global Thromboelastography Analyzer Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital and Clinics
1.3.3 Maternal and Child Health Service
1.3.4 Laboratory
1.3.5 Others
1.4 Global Thromboelastography Analyzer Market Estimates and Forecasts (2020-2031)
1.4.1 Global Thromboelastography Analyzer Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Thromboelastography Analyzer Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Thromboelastography Analyzer Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Thromboelastography Analyzer Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Thromboelastography Analyzer Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Thromboelastography Analyzer Sales Market Share by Region (2020-2025)
2.2.2 Global Thromboelastography Analyzer Revenue Market Share by Region (2020-2025)
2.3 Global Thromboelastography Analyzer Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Thromboelastography Analyzer Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Thromboelastography Analyzer Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Thromboelastography Analyzer Market Size and Prospective (2020-2031)
2.4.2 Europe Thromboelastography Analyzer Market Size and Prospective (2020-2031)
2.4.3 China Thromboelastography Analyzer Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Thromboelastography Analyzer Historic Market Review by Type (2020-2025)
3.1.1 Global Thromboelastography Analyzer Sales by Type (2020-2025)
3.1.2 Global Thromboelastography Analyzer Revenue by Type (2020-2025)
3.1.3 Global Thromboelastography Analyzer Price by Type (2020-2025)
3.2 Global Thromboelastography Analyzer Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Thromboelastography Analyzer Sales Forecast by Type (2026-2031)
3.2.2 Global Thromboelastography Analyzer Revenue Forecast by Type (2026-2031)
3.2.3 Global Thromboelastography Analyzer Price Forecast by Type (2026-2031)
3.3 Different Types Thromboelastography Analyzer Representative Players
4 Global Market Size by Application
4.1 Global Thromboelastography Analyzer Historic Market Review by Application (2020-2025)
4.1.1 Global Thromboelastography Analyzer Sales by Application (2020-2025)
4.1.2 Global Thromboelastography Analyzer Revenue by Application (2020-2025)
4.1.3 Global Thromboelastography Analyzer Price by Application (2020-2025)
4.2 Global Thromboelastography Analyzer Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Thromboelastography Analyzer Sales Forecast by Application (2026-2031)
4.2.2 Global Thromboelastography Analyzer Revenue Forecast by Application (2026-2031)
4.2.3 Global Thromboelastography Analyzer Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Thromboelastography Analyzer Application
5 Competition Landscape by Players
5.1 Global Thromboelastography Analyzer Sales by Players (2020-2025)
5.2 Global Top Thromboelastography Analyzer Players by Revenue (2020-2025)
5.3 Global Thromboelastography Analyzer Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thromboelastography Analyzer as of 2024)
5.4 Global Thromboelastography Analyzer Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Thromboelastography Analyzer, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Thromboelastography Analyzer, Product Type & Application
5.7 Global Key Manufacturers of Thromboelastography Analyzer, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Thromboelastography Analyzer Sales by Company
6.1.1.1 North America Thromboelastography Analyzer Sales by Company (2020-2025)
6.1.1.2 North America Thromboelastography Analyzer Revenue by Company (2020-2025)
6.1.2 North America Thromboelastography Analyzer Sales Breakdown by Type (2020-2025)
6.1.3 North America Thromboelastography Analyzer Sales Breakdown by Application (2020-2025)
6.1.4 North America Thromboelastography Analyzer Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Thromboelastography Analyzer Sales by Company
6.2.1.1 Europe Thromboelastography Analyzer Sales by Company (2020-2025)
6.2.1.2 Europe Thromboelastography Analyzer Revenue by Company (2020-2025)
6.2.2 Europe Thromboelastography Analyzer Sales Breakdown by Type (2020-2025)
6.2.3 Europe Thromboelastography Analyzer Sales Breakdown by Application (2020-2025)
6.2.4 Europe Thromboelastography Analyzer Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Thromboelastography Analyzer Sales by Company
6.3.1.1 China Thromboelastography Analyzer Sales by Company (2020-2025)
6.3.1.2 China Thromboelastography Analyzer Revenue by Company (2020-2025)
6.3.2 China Thromboelastography Analyzer Sales Breakdown by Type (2020-2025)
6.3.3 China Thromboelastography Analyzer Sales Breakdown by Application (2020-2025)
6.3.4 China Thromboelastography Analyzer Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Haemonetics
7.1.1 Haemonetics Company Information
7.1.2 Haemonetics Business Overview
7.1.3 Haemonetics Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Haemonetics Thromboelastography Analyzer Products Offered
7.1.5 Haemonetics Recent Development
7.2 Lepu Technology
7.2.1 Lepu Technology Company Information
7.2.2 Lepu Technology Business Overview
7.2.3 Lepu Technology Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Lepu Technology Thromboelastography Analyzer Products Offered
7.2.5 Lepu Technology Recent Development
7.3 Improve Medical
7.3.1 Improve Medical Company Information
7.3.2 Improve Medical Business Overview
7.3.3 Improve Medical Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Improve Medical Thromboelastography Analyzer Products Offered
7.3.5 Improve Medical Recent Development
7.4 Medcaptain
7.4.1 Medcaptain Company Information
7.4.2 Medcaptain Business Overview
7.4.3 Medcaptain Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Medcaptain Thromboelastography Analyzer Products Offered
7.4.5 Medcaptain Recent Development
7.5 Render
7.5.1 Render Company Information
7.5.2 Render Business Overview
7.5.3 Render Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Render Thromboelastography Analyzer Products Offered
7.5.5 Render Recent Development
7.6 Guizhou Jinjiu Biotech
7.6.1 Guizhou Jinjiu Biotech Company Information
7.6.2 Guizhou Jinjiu Biotech Business Overview
7.6.3 Guizhou Jinjiu Biotech Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Guizhou Jinjiu Biotech Thromboelastography Analyzer Products Offered
7.6.5 Guizhou Jinjiu Biotech Recent Development
7.7 Chongqing Dingrun
7.7.1 Chongqing Dingrun Company Information
7.7.2 Chongqing Dingrun Business Overview
7.7.3 Chongqing Dingrun Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Chongqing Dingrun Thromboelastography Analyzer Products Offered
7.7.5 Chongqing Dingrun Recent Development
7.8 Zhejiang Shengyu
7.8.1 Zhejiang Shengyu Company Information
7.8.2 Zhejiang Shengyu Business Overview
7.8.3 Zhejiang Shengyu Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Zhejiang Shengyu Thromboelastography Analyzer Products Offered
7.8.5 Zhejiang Shengyu Recent Development
7.9 Bio-zircon
7.9.1 Bio-zircon Company Information
7.9.2 Bio-zircon Business Overview
7.9.3 Bio-zircon Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Bio-zircon Thromboelastography Analyzer Products Offered
7.9.5 Bio-zircon Recent Development
7.10 WerfenLife
7.10.1 WerfenLife Company Information
7.10.2 WerfenLife Business Overview
7.10.3 WerfenLife Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.10.4 WerfenLife Thromboelastography Analyzer Products Offered
7.10.5 WerfenLife Recent Development
7.11 Framar Hemologix srl
7.11.1 Framar Hemologix srl Company Information
7.11.2 Framar Hemologix srl Business Overview
7.11.3 Framar Hemologix srl Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Framar Hemologix srl Thromboelastography Analyzer Products Offered
7.11.5 Framar Hemologix srl Recent Development
7.12 Sienco
7.12.1 Sienco Company Information
7.12.2 Sienco Business Overview
7.12.3 Sienco Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Sienco Thromboelastography Analyzer Products Offered
7.12.5 Sienco Recent Development
7.13 Ud-bio
7.13.1 Ud-bio Company Information
7.13.2 Ud-bio Business Overview
7.13.3 Ud-bio Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Ud-bio Thromboelastography Analyzer Products Offered
7.13.5 Ud-bio Recent Development
7.14 WITEYE
7.14.1 WITEYE Company Information
7.14.2 WITEYE Business Overview
7.14.3 WITEYE Thromboelastography Analyzer Sales, Revenue and Gross Margin (2020-2025)
7.14.4 WITEYE Thromboelastography Analyzer Products Offered
7.14.5 WITEYE Recent Development
8 Thromboelastography Analyzer Manufacturing Cost Analysis
8.1 Thromboelastography Analyzer Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Thromboelastography Analyzer
8.4 Thromboelastography Analyzer Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Thromboelastography Analyzer Distributors List
9.3 Thromboelastography Analyzer Customers
10 Thromboelastography Analyzer Market Dynamics
10.1 Thromboelastography Analyzer Industry Trends
10.2 Thromboelastography Analyzer Market Drivers
10.3 Thromboelastography Analyzer Market Challenges
10.4 Thromboelastography Analyzer Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Thromboelastography Analyzer market size was US$ 454 million in 2025 and is forecast to reach a readjusted size of US$ 829 million by 2032 with a CAGR of 9.1% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 97
USD 4250.00
(Single User License)
The global Thromboelastography Analyzer market was valued at US$ 454 million in 2025 and is anticipated to reach US$ 829 million by 2032, at a CAGR of 9.1% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 127
USD 2900.00
(Single User License)
The global market for Thromboelastography Analyzer was estimated to be worth US$ 454 million in 2025 and is projected to reach US$ 829 million, growing at a CAGR of 9.1% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 111
USD 3950.00
(Single User License)
The global Thromboelastography Analyzer market is projected to grow from US$ 420 million in 2024 to US$ 766 million by 2031, at a CAGR of 9.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 152
USD 4900.00
(Single User License)
The global market for Thromboelastography Analyzer was estimated to be worth US$ 420 million in 2024 and is forecast to a readjusted size of US$ 766 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 118
USD 3950.00
(Single User License)
The global market for Thromboelastography Analyzer was valued at US$ 420 million in the year 2024 and is projected to reach a revised size of US$ 766 million by 2031, growing at a CAGR of 9.1% during the forecast period.
Published Date: 2025-01-19
Pages: 89
USD 2900.00
(Single User License)
Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
Published Date: 2024-10-09
Pages: 123
USD 4350.00
(Single User License)
Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
Published Date: 2024-10-09
Pages: 149
USD 4900.00
(Single User License)
Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
Published Date: 2024-10-09
Pages: 123
USD 3950.00
(Single User License)
Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
Published Date: 2024-10-09
Pages: 89
USD 2900.00
(Single User License)
The global Thromboelastography Analyzer market size was US$ 454 million in 2025 and is forecast to reach a readjusted size of US$ 829 million by 2032 with a CAGR of 9.1% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 97
The global Thromboelastography Analyzer market was valued at US$ 454 million in 2025 and is anticipated to reach US$ 829 million by 2032, at a CAGR of 9.1% from 2026 to 2032.
Published: 2026-01-05
Pages: 127
The global market for Thromboelastography Analyzer was estimated to be worth US$ 454 million in 2025 and is projected to reach US$ 829 million, growing at a CAGR of 9.1% from 2026 to 2032.
Published: 2026-01-05
Pages: 111
The global Thromboelastography Analyzer market is projected to grow from US$ 420 million in 2024 to US$ 766 million by 2031, at a CAGR of 9.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 152
The global market for Thromboelastography Analyzer was estimated to be worth US$ 420 million in 2024 and is forecast to a readjusted size of US$ 766 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 118
The global market for Thromboelastography Analyzer was valued at US$ 420 million in the year 2024 and is projected to reach a revised size of US$ 766 million by 2031, growing at a CAGR of 9.1% during the forecast period.
Published: 2025-01-19
Pages: 89
Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
Published: 2024-10-09
Pages: 123
Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
Published: 2024-10-09
Pages: 149
Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
Published: 2024-10-09
Pages: 123
Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
Published: 2024-10-09
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now